U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
ODRONEXTAMAB
INN   USAN  
Official Name English
REGN-1979
Code English
ANTI-CD20/CD3 MONOCLONAL ANTIBODY REGN1979
Common Name English
IMMUNOGLOBULIN G4-KAPPA ANTI-(HOMO SAPIENS B-LYMPHOCYTE ANTIGEN CD20), HETERO DIMER WITH IMMUNOGLOBULIN G4-KAPPA ANTI-(HOMO SAPIENS T-CELL SURFACE GLYCOPROTEIN CD3 EPSILON CHAIN) HUMAN MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-453) (HOMO SAPIENS VH (IG
Common Name English
ANTI-CD20 X ANTI-CD3 BISPECIFIC MONOCLONAL ANTIBODY REGN1979
Common Name English
odronextamab [INN]
Common Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN REGN1979 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN REGN1979 .KAPPA.-CHAIN, DIMER WITH IMMUNOGLOBULIN G4, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN REGN1979 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN REGN1979 .KAPPA.-CHAIN
Common Name English
ODRONEXTAMAB [USAN]
Common Name English
MAB HUMAN (IGG4) ANTI P11836 (CD20_HUMAN) & ANTI P07766 (CD3E_HUMAN) (REGN1979)
Common Name English
REGN1979
Code English
Odronextamab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 623317
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
FDA ORPHAN DRUG 569816
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
Code System Code Type Description
FDA UNII
8R5CM46UIO
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
PRIMARY
NCI_THESAURUS
C119615
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
PRIMARY
USAN
EF-150
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
PRIMARY
INN
11035
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
PRIMARY
CAS
1801338-64-6
Created by admin on Sat Dec 16 13:39:19 GMT 2023 , Edited by admin on Sat Dec 16 13:39:19 GMT 2023
PRIMARY
ACTIVE MOIETY
ODRONEXTAMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966